BRGX — BioRegenx Cashflow Statement
0.000.00%
Last trade - 00:00- $38.17m
- $39.89m
- $0.02m
- 48
- 28
- 12
- 20
Annual cashflow statement for BioRegenx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | 10-K | 10-K | 10-K | 10-K |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.43 | -0.085 | -0.262 | -0.117 | -0.592 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | 0.023 | 0.165 | 0.039 | 0.564 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.17 | -0.038 | -0.027 | 0.008 | 0.009 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.26 | -0.094 | -0.12 | -0.065 | -0.013 |
| Capital Expenditures | -0.237 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.944 | — | — | 0 | 0 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.18 | — | — | 0 | 0 |
| Financing Cash Flow Items | 3.48 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.67 | 0.15 | 0.05 | 0.041 | 0.013 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.232 | 0.056 | -0.07 | -0.024 | -0.001 |